Live tape
Top 8, mentions 7d7,542NKE2,120 mentions▲ +0.03GOOGL1,413 mentions▲ +0.04NVDA837 mentions▲ +0.10QQQ712 mentions▲ +0.09SPCX673 mentions▲ +0.09META655 mentions▲ +0.04TSLA632 mentions▲ +0.06MSFT500 mentions▲ +0.04

Equity · Healthcare

VVOS

NASDAQ

Vivos Therapeutics, Inc.

$0.4156 +2.29% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart
8 sessions
$0.48 $0.40 8 Jul 17 Jul

The line runs $0.4798 on 8 July through $0.4156 on 17 July, on a scale from $0.40 to $0.48. Days the market did not trade hold the previous close, flat.

Market cap $8.4M
Avg volume 116.4K

as of Jul 17, 2026

Filings 4 sets

VVOS reported financials

SEC EDGAR XBRL SEC EDGAR

VVOS reported revenue of $17.4M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$21.2M.

Figure Reported Period
Revenue $17.4M 31 Dec 2025 fiscal year
Net income −$21.2M 31 Dec 2025 fiscal year
Diluted EPS −$2.07 31 Dec 2025 fiscal year
Total assets $24.1M 30 Jun 2026 at period end
Total equity −$3.8M 30 Jun 2026 at period end

VVOS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.31 $5M
31 Mar 2026 Q1 2026 −$0.52 $5M
31 Dec 2025 FY 2025 −$2.07 $17M
30 Sep 2025 Q3 2025 −$0.49 $7M
30 Jun 2025 Q2 2025 −$0.55 $4M
31 Mar 2025 Q1 2025 −$0.45 $3M
31 Dec 2024 FY 2024 −$2.22 $15M
30 Sep 2024 Q3 2024 −$0.40 $4M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

VVOS institutional holders

SEC Form 13F SEC EDGAR

0 of the 45 institutional funds we track reported a VVOS position for the quarter ended 31 Dec 2025; the latest of those filings landed 12 Feb 2026.

Fund Action Shares Value

VVOS fails-to-deliver

SEC CNS data SEC

On 14 Sep 2026, 8,229 shares of VVOS failed to deliver (about $1K).

Settlement date Shares failed Notional % of shares out
14 Sep 2026 8,229 $1K 0.041%
10 Sep 2026 354 $60 0.002%
09 Sep 2026 3,329 $599 0.017%
08 Sep 2026 2,245 $427 0.011%
03 Sep 2026 138,153 $23K 0.687%
02 Sep 2026 410,370 $70K 2.040%
01 Sep 2026 11,976,326 $2.4M 59.530%
31 Aug 2026 75,983 $17K 0.378%
28 Aug 2026 4,836 $1K 0.024%
27 Aug 2026 269,920 $67K 1.342%
26 Aug 2026 11,879 $3K 0.059%
25 Aug 2026 45 $13 <0.001%
24 Aug 2026 2,217 $665 0.011%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings